Posted 26 March, 2021
Design Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:DSGN in a 424B4 filed on 26 March, 2021.
This is the initial public offering of shares of common stock of Design Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Design Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.Market Cap
$155M
View Company Details
$155M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.